Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Similar documents
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

Phone: +44 (0) or BioPortfolio Limited

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Critical Limb Ischemia - Pipeline Review, H1 2017

State of Licensing 2011 Update

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

United States Sterilization Equipment Market Outlook to 2021

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Digital Health Funding and M&A

Venture Capital Report

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

Venture Capital Report

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

2013 Global venture capital confidence survey results. How confident are investors?

VentureSource Europe -- 3Q 2014

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

Master Class : Excellence in Private Equity & Deal Structuring

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

Intellectual property governance and strategic value creation:

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

Presentation. March 2007

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

JAPAN M+A A N N u A l r e v i e w

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

CeQur establishes Wales subsidiary

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board

World Offshore Wind Market Forecast Prospects, Technologies, World Markets

PRESENTATION ON PRIVATE EQUITY 16 th January, 2017 at the Institute of Chartered Accountants of India, EIRC

2014 Global venture capital confidence survey results

Report on Global Sneaker Market by Player, Region, Type, Application and Sales Channel.pdf

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

New York Bar admission (or eligibility to obtain admission promptly) is required.

Global Paper Stationery Market Research Report 2016

Venture Capital Report

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

MassMEDIC Annual Meeting

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association

Strategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd.

Indoor Positioning and Navigation System Market Research Report- Forecast 2023

Venture Capital Report

Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden

PRESS KIT 2018 BARENTZ INTERNATIONAL BV

INDIA Market Projections and Developments

Omeros Raises More Than $63 Million in Financing

HISTORY, REORGANISATION AND CORPORATE STRUCTURE

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Venture Capital Report

Global and China Industrial Robot Industry Report, Sep. 2013

Purvi B. Maniar Member of the Firm

The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP

Lupin Limited Annual Results FY12. Investor Presentation May being

A Citation-Based Patent Evaluation Framework to Reveal Hidden Value and Enable Strategic Business Decisions

GLOBAL PRIVATE EQUITY Report Charts

Speaker/Panelist Profiles

Global and China Industrial Robot Speed Reducer Industry Report, Jun. 2014

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Transcription:

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Emcure Pharmaceuticals Ltd (Emcure) is a pharmaceutical company that develops, manufactures and markets a wide range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. Emcure also manufactures active pharmaceutical ingredients (APIs) primarily for use in manufacturing of pharmaceutical products. Emcure has presence in all major therapeutic areas including cardiology, pain and analgesics, HIV, gynecology, blood related, anti-infective, nephrology, diabetes, oncology, and vitamins, minerals and nutrients products. It operates subsidiaries in Brazil, Dubai, South Africa, Singapore and Nigeria. The company has branch offices in Russia and Morocco. Emcure is headquartered in Pune, Maharashtra, India. Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3

the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH141651D Number of Pages : 30 Report Format : PDF Publisher Information : 4

5

Table Of Contents for Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 12Asset Purchase 12Emcure Pharma to Acquire Seven Drugs from Sun Pharma and Ranbaxy Labs 12Emcure Pharma Acquires Rights of BiCNU Injection from Bristol-Myers Squibb 13Private Equity 14Bain Capital To Acquire 13.09% Stake In Emcure Pharma From Blackstone 14Partnerships 16Sanofi Enters into Distribution Agreement with Emcure for Oncology Drugs 16Roche Enters Into Technology Transfer Agreement With Emcure Pharma For Two Patented Cancer Drugs 17Sanofi Pasteur India Enters Into Co-Marketing Agreement With Emcure Pharma For Rabies Vaccine 19Licensing Agreements 20Emcure Pharma Enters into Licensing Agreement with Medicines Patent Pool 20Emcure Pharma Enters into Licensing Agreement Desano Pharma 21Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 22Equity Offering 24Emcure Pharma Withdraws IPO 24Acquisition 25Emcure Pharma Acquires International Pharma Generics and Marcan Pharma 25Emcure Pharmaceuticals Ltd - Key Competitors 26Key Employees 27Locations And Subsidiaries 28Head Office 28Other Locations & Subsidiaries 28Appendix 30Methodology 30About GlobalData 30Contact Us 30Disclaimer 30 6

List Of Tables in Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 1 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Emcure Pharmaceuticals Ltd, Deals By Therapy Area, 2010 to YTD 2016 8 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 Emcure Pharma to Acquire Seven Drugs from Sun Pharma and Ranbaxy Labs 12 Emcure Pharma Acquires Rights of BiCNU Injection from Bristol-Myers Squibb 13 Bain Capital To Acquire 13.09% Stake In Emcure Pharma From Blackstone 14 Sanofi Enters into Distribution Agreement with Emcure for Oncology Drugs 16 Roche Enters Into Technology Transfer Agreement With Emcure Pharma For Two Patented Cancer Drugs 17 Sanofi Pasteur India Enters Into Co-Marketing Agreement With Emcure Pharma For Rabies Vaccine 19 Emcure Pharma Enters into Licensing Agreement with Medicines Patent Pool 20 Emcure Pharma Enters into Licensing Agreement Desano Pharma 21 Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 22 Emcure Pharma Withdraws IPO 24 Emcure Pharma Acquires International Pharma Generics and Marcan Pharma 25 Emcure Pharmaceuticals Ltd, Key Competitors 26 Emcure Pharmaceuticals Ltd, Key Employees 27 Emcure Pharmaceuticals Ltd, Subsidiaries 28 7

List Of Figures, Charts and Diagrams in Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 8

How to Buy... Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9